CLOFIBRATE ALUMINIUM

Clofibrate aluminum has similar lipidlowering properties with altered pharmacokinetics. Side effects include nausea and rare hepatotoxicity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 06fb60e171e9 Category: Tag:

Product Description


Mechanism of Action

Clofibrate aluminium is a lesssoluble complex of clofibrate providing modified release and altered absorption properties. Mechanism identical: PPAR activation leading to triglyceride reduction and improved lipid transport.

Benefits and Advantages

Used in formulationrelease profiling, saltform pharmacokinetics, lipidregulation modelling and PPAR signalling research.

Side Effects and Risks

Risks are similar to clofibrate but with potential aluminiumrelated GI effects. Handle as a metalassociated fibrate compound.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C12H15ClO3·Al

Molecular Weight

290.5 g/mol

CAS Number

637-07-0

Storage Condition

Store in a cool, dry place; protect from light

Solubility

Soluble in water

Purity

Purity information is available upon request (COA).

Synonym

clofibrate; 637-07-0; Ethyl 2-(4-chlorophenoxy)-2-methylpropanoate; Ethyl clofibrate; Atromid-S

IUPAC/Chemical Name

2-(4-chlorophenoxy)-2-methylpropanoate aluminium salt

InChl Key

Unavailable

InChl Code

Unavailable

References

PubChem; ChemBL; FDA;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download